MARKET NEWS

Verseon Reports First Dosing in Phase 1 Trial on New Precision Oral Drug
ProteoNic Biotechnology Licenses Protein Production Technology to Eli Lilly
HiberCell Launches to Prevent Cancer Relapse & Metastasis With Novel Therapeutics
Evotec & Galapagos Enter Global Collaboration
argenx & Halozyme Enter Global Collaboration & License Agreement
AIT Receives Milestone Payment From Commercialization Partner

  FEATURED EDITORIAL

  COMPANY PROFILE

Credence MedSystems is setting a new standard in drug delivery, helping you differentiate your products through innovative delivery systems while preserving your trusted processes. Simple, safe, and intuitive usability creates a better, safer experience for patients and healthcare professionals. Innovative designs provide safety activation clicks, end-of-dose feedback cues, and automatic needle retraction—without changes to familiar injection procedures. Click here for more.

EG-GILERO is your single-source, trusted partner for design, development and contract manufacturing within the medical device, drug delivery, and primary pharmaceutical packaging markets. Acting as a seamless extension of your own internal resources, we accelerate speed to market of innovative devices from concept straight through commercialization. Click here for more.

  EXCLUSIVE ONLINE CONTENT

West Annouces Significant Agreements With Swissfillon & scPharmaceuticals

West Annouces Significant Agreements With Swissfillon & scPharmaceuticals

West recently announced it has commenced discussions with two companies regarding the use of West’s proprietary SmartDose drug delivery platform for complex molecules.

uniQure Announces First Patient Treated in Pivotal Trial

uniQure Announces First Patient Treated in Pivotal Trial

uniQure N.V. recently announced it treated the first patient in its HOPE-B pivotal trial of AMT-061, an investigational AAV5-based gene therapy incorporating the patent-protected FIX-Padua variant for the treatment of patients with severe and moderately severe hemophilia B.

Meridian Launches New Range of Lyo-Ready PCR Mixes

Meridian Launches New Range of Lyo-Ready PCR Mixes

Meridian Bioscience, Inc. recently announced that following the successful release of the Lyo-Ready qPCR Mix, Meridian is proud to introduce its next-generation lyophilization-ready mixes for one-step RT-qPCR.

  DRUG DEVELOPMENT DIRECT RESOURCES

Upcoming eNewsletter Features:

February 20 – Formulation Development
February 27 – ODT/Fast Dissolve